-
1
Hindering triple negative breast cancer progression by targeting endogenous interleukin‐30 requires IFNγ signaling
Published 2021-02-01Subjects: Get full text
Article -
2
Targeting Interleukin(IL)-30/IL-27p28 signaling in cancer stem-like cells and host environment synergistically inhibits prostate cancer growth and improves survival
Published 2019-07-01Subjects: “…Interleukin-30…”
Get full text
Article -
3
CRISPR/Cas9-mediated deletion of Interleukin-30 suppresses IGF1 and CXCL5 and boosts SOCS3 reducing prostate cancer growth and mortality
Published 2022-10-01Subjects: Get full text
Article -
4
-
5
Interleukin-30 Suppresses Not Only CD4<sup>+</sup> T Cells but Also Regulatory T Cells in Murine Primary Biliary Cholangitis
Published 2021-08-01Subjects: Get full text
Article -
6
Decoding the Role of Interleukin-30 in the Crosstalk between Cancer and Myeloid Cells
Published 2020-03-01Subjects: Get full text
Article